| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Section of Hematology/Oncology, Children's Hospital of Pittsburgh; 2 University of Pittsburgh Cancer Institute; 3 Department of Molecular Genetics and Biochemistry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and 4 Department of Molecular Biology, Brown University, Providence, Rhode Island
Requests for reprints: Edward V. Prochownik, Section of Hematology/Oncology, Children's Hospital of Pittsburgh, Rangos Research Center, Room 2100, 3460 Fifth Avenue, Pittsburgh, PA 15213. Phone: 412-692-6797; Fax: 412-692-5228; E-mail: PROCEV{at}chp.edu.
C-MYC, a transforming oncogene that is frequently overexpressed in many human cancers, regulates a variety of normal functions including cell cycle progression, apoptosis, and maintenance of cell size, morphology, and genomic integrity. Many target genes are modulated by c-Myc, and some can recapitulate a limited number of the above functions. Because most of these have been assessed in cells which also express endogenous c-Myc, however, it is not clear to what extent its proper regulation is also required. We show here that, in c-Myc nullizygous cells, two direct target genes, MT-MC1 and HMG-I, could each recapitulate multiple c-Myc phenotypes. Although these differ somewhat for the two genes, substantial overlap and cooperativity exist. The enforced expression of these two genes was also associated with the differential deregulation of some previously described c-Myc target genes, indicating the presence of a complex molecular circuitry. These observations argue that, despite the great diversity of gene regulation by c-Myc, many, although not all, of its functions can be phenocopied by a small subset of key downstream target genes. The approach described here should permit the identification of other target genes capable of further c-Mycindependent complementation.
Key Words: c-Myc max MT-MC1 HMG-I/Y F-actin cell cycle
This article has been cited by other articles:
![]() |
J. A. Graves, M. Metukuri, D. Scott, K. Rothermund, and E. V. Prochownik Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc J. Biol. Chem., March 6, 2009; 284(10): 6520 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Lu, and E. V. Prochownik Modularity of the Oncoprotein-like Properties of Platelet Glycoprotein Ib{alpha} J. Biol. Chem., January 16, 2009; 284(3): 1410 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Niapour, Y. Yu, and S. A. Berger Regulation of Calpain Activity by c-Myc through Calpastatin and Promotion of Transformation in c-Myc-negative Cells by Calpastatin Suppression J. Biol. Chem., August 1, 2008; 283(31): 21371 - 21381. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, D. I. Hammoudeh, A. V. Follis, B. E. Reese, J. S. Lazo, S. J. Metallo, and E. V. Prochownik Improved low molecular weight Myc-Max inhibitors Mol. Cancer Ther., September 1, 2007; 6(9): 2399 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Lu, and E. V. Prochownik Dual Role for SUMO E2 Conjugase Ubc9 in Modulating the Transforming and Growth-promoting Properties of the HMGA1b Architectural Transcription Factor J. Biol. Chem., May 4, 2007; 282(18): 13363 - 13371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tesfaye, F. Di Cello, J. Hillion, B. M. Ronnett, O. Elbahloul, R. Ashfaq, S. Dhara, E. Prochownik, K. Tworkoski, R. Reeves, et al. The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis Cancer Res., May 1, 2007; 67(9): 3998 - 4004. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Lu, and E. V. Prochownik c-Myc-mediated genomic instability proceeds via a megakaryocytic endomitosis pathway involving Gp1b{alpha} PNAS, February 27, 2007; 104(9): 3490 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Rogulski, Q. Zhou, P. J. Sims, and E. V. Prochownik The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase I. Mol. Cell. Biol., May 1, 2006; 26(9): 3401 - 3413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik Deregulation of common genes by c-Myc and its direct target, MT-MC1 PNAS, December 27, 2005; 102(52): 18968 - 18973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |